Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial
Titel:
Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial
Auteur:
Ree, Isabelle M C de Haas, Masja van Geloven, Nan Juul, Sandra E de Winter, Derek Verweij, E J T Oepkes, Dick van der Bom, Johanna G Lopriore, Enrico